These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37218417)

  • 1. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
    Burger PM; Pradhan AD; Dorresteijn JAN; Koudstaal S; Teraa M; de Borst GJ; van der Meer MG; Mosterd A; Ridker PM; Visseren FLJ;
    Am J Cardiol; 2023 Jun; 197():13-23. PubMed ID: 37218417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease.
    Hageman SHJ; de Borst GJ; Dorresteijn JAN; Bots ML; Westerink J; Asselbergs FW; Visseren FLJ;
    Heart; 2020 Nov; 106(21):1686-1692. PubMed ID: 32170038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.
    van Wijk DF; Boekholdt SM; Wareham NJ; Ahmadi-Abhari S; Kastelein JJ; Stroes ES; Khaw KT
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2888-94. PubMed ID: 24072695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
    Burger PM; Koudstaal S; Mosterd A; Fiolet ATL; Teraa M; van der Meer MG; Cramer MJ; Visseren FLJ; Ridker PM; Dorresteijn JAN;
    J Am Coll Cardiol; 2023 Aug; 82(5):414-426. PubMed ID: 37495278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of resting heart rate on vascular events and mortality in vascular patients.
    Bemelmans RH; van der Graaf Y; Nathoe HM; Wassink AM; Vernooij JW; Spiering W; Visseren FL;
    Int J Cardiol; 2013 Sep; 168(2):1410-5. PubMed ID: 23305859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort study.
    Yoshinaga R; Doi Y; Ayukawa K; Ishikawa S
    BMJ Open; 2017 Oct; 7(10):e015112. PubMed ID: 28988163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of Blood Pressure-Lowering Drug Trials to Real-World Patients With Cardiovascular Disease.
    Bonekamp NE; Spiering W; Nathoe HM; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Hypertension; 2021 Feb; 77(2):357-366. PubMed ID: 33342237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
    Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population.
    Hendriks EJ; Westerink J; de Jong PA; de Borst GJ; Nathoe HM; Mali WP; van der Graaf Y; van der Schouw YT; Beulens JW;
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):412-7. PubMed ID: 26715681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
    Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
    Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.
    Cao JJ; Arnold AM; Manolio TA; Polak JF; Psaty BM; Hirsch CH; Kuller LH; Cushman M
    Circulation; 2007 Jul; 116(1):32-8. PubMed ID: 17576871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.